Every rejected submission costs months
Submission material review
AI-powered compliance review of PBS submissions, PBAC materials, and value dossiers. Every claim scored against the PI and Medicines Australia Code.
Compliance confidence
Ensure market access materials meet regulatory requirements before they reach review committees. Reduce rejection cycles.
Competitive landscape
Use KOL Intelligence to understand competitor engagement patterns. See which HCPs and advisors are shaping market access decisions.
Payer engagement
Deploy compliant conversational agents to support payer education. Provide real-time, PI-grounded responses to formulary and access questions.
Evidence gap analysis
Identify where your clinical evidence needs strengthening. Track which claims reviewers challenge most.
Stakeholder mapping
Map the advisory and consulting relationships that influence market access decisions.
Trusted by pharma, life sciences companies and their agencies
Platform features
Evidence-led, compliant engagement
Designed for non-promotional, value-based exchange.
- Train on approved value dossiers and evidence packages
- Control responses by geography, role, and system
- Maintain strict separation from commercial messaging
Clear answers to complex access questions
Provide fast, structured responses to the questions that stall access decisions.
- Value propositions and unmet need
- Health economic models and assumptions
- Budget impact and cost-effectiveness
- Reimbursement criteria and restrictions
- Outcomes data and comparators
Reduce friction in payer engagement
Make evidence easy to access without repeated follow-ups or long email threads.
- 24/7 availability for access stakeholders
- Consistent, accurate responses
- Faster resolution of standard evidence requests
One question away from the right document
Surface the right data without forcing stakeholders to navigate complex portals.
- Global and local value dossiers
- HEOR models and summaries
- RWE and outcomes studies
- Policy and guideline context
Deploy across access touch-points
Support engagement across the payer journey.
- Embed in payer portals and access hubs
- Email for asynchronous evidence requests
- SMS (coming soon) for follow-up clarifications
- Voice (coming soon) for conversational access support
Capture real-world access intelligence
Understand what blocks, delays or enables access at scale.
- Track recurring objections and questions
- Identify evidence gaps by market or region
- Monitor sentiment around pricing and value
- Inform negotiation and submission strategies
Strengthen field access effectiveness
Equip access teams with insight, not guesswork.
- See which stakeholders engage and on what topics
- Prioritise follow-ups based on real interest
- Align field messaging with actual needs
Understand the landscape before you engage
Submission material review
AI-powered compliance review of PBS submissions, PBAC materials, and value dossiers. Every claim scored against the PI and Medicines Australia Code.
Compliance confidence
Ensure market access materials meet regulatory requirements before they reach review committees. Reduce rejection cycles.
Competitive landscape
Use KOL Intelligence to understand competitor engagement patterns. See which HCPs and advisors are shaping market access decisions.
Payer engagement
Deploy compliant conversational agents to support payer education. Provide real-time, PI-grounded responses to formulary and access questions.
Evidence gap analysis
Identify where your clinical evidence needs strengthening. Track which claims reviewers challenge most.
Stakeholder mapping
Map the advisory and consulting relationships that influence market access decisions.